Infertility. Diseases of male genital organs,Male infertility,
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Men 20-45 years Infertility for at least one year Unexplained Oligo-astheno-teratozoospermia according to WHO criteria: Sperm concentrations below 20 million per milliliter; 5. Motile sperm less than 50%; 6. The normal morphology less than 30%
Exclusion criteria
Exclusion criteria: History of taking chemotherapy, Corticosteroid, Anticoagulation, Testosterone, Antiandrogen The incidence of severe cases of oligospermia (sperm concentration less than one million per milliliter) Infections, genital anatomical abnormalities, chromosomal abnormalities, history of surgery on the genital tract, exposure to toxins Alcohol or drug abuse Systemic diseases (cancer, thyroid disease, liver and gall bladder diseases, renal failure, etc.) The reluctance of patients to continue Make any side effects from medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Semen volume. Timepoint: At the begining of the trial, 3 months after end of the drug. Method of measurement: Semen analysis.;Sperm count. Timepoint: At the begining of the trial, 3 months after end of the drug. Method of measurement: Sperm analysis.;Sperm motility. Timepoint: At the begining of the trial, 3months after end of the drug. Method of measurement: Semen analysis.;Normal morphology. Timepoint: At the begining of the trial, 3months after end of the dru. Method of measurement: Semen analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fertility. Timepoint: After treatment. Method of measurement: Partner pregnancy.;Side effects such as itching, etc. Timepoint: During the intervention. Method of measurement: Patient report. | — |
Countries
Iran (Islamic Republic of)
Contacts
School of Persian Medicine, Iran University of Medical Sciences